|
Drug Watch
International (From Health Canada Report, 2000) Absorption:
The process by which a chemical (substance) is transported and taken up into
living tissues of the body. Acute
Toxicity: The damaging effects observed in short term toxicity studies
usually involving a single dose of a chemical or multiple dose given within 24
hours Adenoma: A benign epithelial tumour with a gland-like
structure. Additive
Effect: The effect of two or more chemicals acting together such that
their combined effect is equivalent to the sum of their individual effects. Administered
Dose: The amount of chemical (substance) given to an animal or human. Agonist:
A chemical that by binding to a specific receptor binding site causes the
normal functioning of the receptor (opposite of antagonist). Anandamide
(ANA): arachidonylethanolamide; a substance that is normally present in
the body and binds to the cannabinoid receptor. Androgens:
Hormones produced in the male gonads required for gamete (sperm) production.
In humans the most important androgen secreted by the testes is testosterone,
other androgens produced in the testes include dihydrotestosterone,
androstenedione and dehydroepiandrosterone, and small amounts of pregnenolone
and progesterone. Aneuploidy:
having at least one more or one less chromosome than the usual diploid number;
usually occurs as a result of an error during meiosis. Antagonist: A chemical that competes with the agonist for the same receptor binding site and binds to the receptor macromolecule without altering the receptor’s function. Thus, the antagonist prevents binding and effectively blocks the biologic actions of agonist molecules. Antagonist:
When referring to interactions with a cellular receptor an antagonist is a
chemical that has affinity for a particular receptor binding site and by
binding to this site blocks the binding of the natural ligand resulting in
interruption of the proper functioning of the receptor. Antagonistic
Effect: When referring to effects of more than one chemical: The
interaction of more than one chemical, such that presence of one chemical
counteracts the effect of the other chemical. Thus, simultaneous
exposure to two such chemicals has less effect than the simple sum of their
individual effects. Application
Rate: Amount of product (g) applied to the surface area (m2) of
the skin with the units g/m2. Astrocytoma: a
malignant type of brain tumour Bioaccumulative/Bioaccumulation: The tendency of a lipophilic chemical to partition to fatty tissues in biological systems and to accumulate to greater concentrations in these tissues over time. Bioassays:
Tests conducted using living organisms. Biogenic
Amines: Biologically active chemicals synthesized from amino acids that
act as neurotransmitters in the nervous system (e.g. acetylcholine,
epinephrine, norepinephrine, serotonin, dopamine). Cannabinoid
Receptor: A protein that spans the cell membrane and provides a specific
site for which cannabinoids have an affinity. Cannabinoids:
A family of chemicals with similar structure produced in Cannabis
plants (see main report Figure 1 for some structures). Carcinoma: A malignant growth of epithelial cells that may
spread to other parts of the body. Catecholamines:
Biogenic amines with a specific chemical base structure, including adrenaline,
noradrenaline and dopamine. Catecholaminergic
Neurons: Nerve cells that release catecholamines. CBC:
Cannabichromene, belongs to the cannabinoid family of chemicals
produced in Cannabis plants. CBD:
Cannabidiol, belongs to the cannabinoid family of chemicals found in Cannabis sativa. CBG:
Cannabigerol, belongs to the cannabinoid family of chemicals found in Cannabis sativa. CBN:
Cannabinol, belongs to the cannabinoid family of chemicals found in
Cannabis sativa. Cerebellum:
A subdivision of the brain located in the lower back portion and involved with
skeletal muscle functions, maintenance of balance and smooth movements. Chromosomal
Aberrations:
Abnormalities in the physical structure of the chromosome. Chronic
Toxicity: The damaging effects of a long term exposure to a chemical. Clastogenic
Effects:
Disruptions or breakages of chromosomes. Dermal
Absorption: The relative amount of chemical (%) applied to the skin that
is taken up by the body. Dermal
Permeability:
The rate at which a chemical penetrates the skin, expressed as the
permeability coefficient (or flux normalized for concentration) in units of
cm/hour. Delta-9-tetrahydrocannabinol
(THC): The cannabinoid found in in Cannabis
sativa that is considered to be the principle component responsible for
its psychoactive effects. Also
known as delta-1-tetrahydrocannabinol. Considered for this report to be
equivalent to delta-8-tetrahydrocannabinol (a minor cannabinoid that is
structurally similar to THC). Dominant
Lethal Mutation: A mutation carried on the Y chromosome that causes death
those affected. Dopamine:
A neurotransmitter that plays a role in the control of movement. Dopaminergic
Neurons: Nerve cells that release dopamine. Dose:
The amount of a chemical administered to an organism.
Applied dose is the amount of chemical presented to an absorption
barrier (not yet having crossed it). Delivered dose is that amount that
crosses the absorption barrier into systemic circulation. Dose-Response
Assessment: The determination of the relationship between the magnitude of
the dose of chemical administered and the occurrence of health effects of
concern. Dose-Response
Curves: The curve that characterizes the relationship between the dose and
the magnitude of a graded effect, in an individual or a population. A variety
of forms of the curve are possible. Within a given dose range, the curve may
or may not be linear. Double
Blind Placebo-Controlled Study: In a double blind study neither the
researcher nor the subject knows whether the test substance or a placebo
(inactive substance that appears similar to the test substance) has been given
until the study is completed. Dronabinol
(THC): A synthetic cannabinoid used as a therapeutic. Endogenous:
Originating from within the organism. Endogenous
Cannabinoid: A natural chemical synthesized in the body that binds to and
activates the cannabinoid receptor. Endogenous
Cannabinoid System: The collection of cannabinoid receptors and the
cannabinoids that bind to these. Estradiol (17-b-E2): Estradiol is the major secretory product of the ovary. Estrogens:
The group of steroid hormones that control female reproductive development and
functioning. Estrous: The menstrual phase of the menstrual cycle. Exposure
Assessment: The
estimation (qualitative or quantitative) of the magnitude, the frequency,
duration and route of exposure to chemical(s) or substance(s) that a consumer
(in this report: adult female, adult male, child) would likely take in
internally during product(s) use or lifestyle habits. Exposure
Scenario(s): Set of
conditions, facts, assumptions and inferences that describe the circumstances
affecting exposure of an individual or population being assessed. These
include the route of exposure, the quantity of the material used, the
frequency and duration of use. Together these aid the exposure assessor in
evaluating, estimating or quantifying exposures to chemical(s) or substance(s)
of concern. Fetotoxicity: Damaging effects to the developing fetus in the womb (in humans the fetal stage is reached after about three months of pregnancy, prior to which is the embryo stage). FSH:
Follicle-Stimulating Hormone is a glycoprotein hormone produced in the
anterior pituitary. FSH and LH together regulate gonadal function. FSH
principally stimulates gametogenesis and follicular development in females and
spermatogenesis in males. In the ovary, FSH acts on the immature follicular
cells and initiates development of the mature follicle and oocyte. In the
testes, FSH acts on Sertoli cells stimulating their production of androgen
building protein. GD: Gestation Day. (e.g. GD1-end is the period of time from Gestation Day one to end of gestation) Genotoxicity: Damaging effects of exposure to a chemical or
substance to genetic material (nucleic acids) of living cells. Gonadectomized
rats: Laboratory rats that have had their gonads removed. Gonadotropins:
Hormones that stimulate egg and sperm production and sex hormone synthesis
(luteinizing hormone - LH and follicular stimulating hormone - FSH). Gonadotropin
Releasing Hormone: Hormones released from the hypothalamus that stimulate
the pituitary to secrete LH and FSH. Hazard Assessment: Identification of specific health hazards of chemical(s) and substances(s) of concern determined through critical review of the scientific hazard data. Identification of No-Observed-Effect-Level(s) or Low-Observed-Effect-Level(s) for the chemical(s) or substances(s) of concern. hCG:
Human Chorionic Gonadotropin. This hormone is produced by the human
placenta. Its function is to stimulate the ovarian corpus luteum to produce
progesterone and maintain placenta. hCG stimulates gonadal steroid hormones. Hepatocellular Adenoma: A benign liver tumour. Heritable
Translocations: Errors in chromosomes that are passed to the next
generation. Histopathology: Identification of pathological changes in
tissues at a microscopic level. Human
Epidemiology Studies: Studies of health effects observed to occur in human
populations in association with an identified stressor(s) and the relationship
of various factors modifying the frequency and distribution of diseases in a
human community. Hydrophobic: Literally “water hating”, the property of a chemical such
that it has the tendency to “flee” from aqueous phase; opposite of
hydrophilic or “water loving”. Hypothalamic
Alteration: A disruption to the normal function of the hypothalamus
causing subsequent effects on hormonal processes. Hypothalamus: A tiny area of the brain responsible for the
correlation of neural and endocrine functions. The most important area of the
brain for regulation of the internal environment. It is also associated with
emotions. Hypothalamus-Pituitary-Gonadal Axis:
The interaction of the hypothalamus (secretes releasing hormones that
stimulate the pituitary), the pituitary (secretes gonadotropins that control
the gonads) and the gonads (secretes sex hormones which give negative feed
back to the hypothalamus that controls the secretion of releasing hormones). Hypothalamus-Pituitary-Adrenal Axis: The
interaction of the hypothalamus (secretes releasing hormones that stimulate
the pituitary), the pituitary (secretes adrenocorticotropic hormone that
stimulates the adrenal gland) and the adrenal gland (secretes androgens which
give negative feed back to the hypothalamus that controls the secretion of
releasing hormones). Immunotoxic: Damaging effects to the immune system. Industrial
Hemp: Cannabis sativa (as defined in the Industrial Hemp Regulations 1089,
Health Canada, 1998) that contains < 0.3% (w/w)
delta-9-tetrahydrocannabinol (THC). Industrial
Hemp Meal: The pressed seed cake of industrial hemp seed. Industrial Hemp Nut: The hulled (de-shelled) industrial hemp seed. Industrial
Hemp Oil: Oil that is
cold pressed from industrial hemp seeds. Industrial
Hemp Seed: Seed from mature Cannabis
sativa (industrial hemp variety) plants. In
Utero: in the womb i.m. Injection: Intramuscular injection i.p.
Injection: Intraperitoneal injection i.v.
Injection: Intravenous injection of a chemical or drug. In
Vivo: Literally “in life,” a study conducted using living intact
organisms. In
Vitro: Literally “in glass,” a study conducted in a vessel (glass
container or diffusion cell) using excised tissues, enzyme preparations or
microorganisms. LH:
Luteinizing Hormone is a glycoprotein hormone produced by the anterior
pituitary. LH is primarily involved in the control of gonadal steroid hormone
production. In the testes, LH stimulates Leydig cells to produce testosterone.
In the ovary, LH and FSH together stimulate follicular development. LH induces
ovulation by the mature follicle, and stimulates the corpus luteum in the
luteal phase of the menstrual cycle to produce progesterone and androgens. LHRH:
Luteinizing Hormone Releasing Hormone. Produced by the hypothalamus, this
hormone controls the release of the gonadotropin LH by the pituitary. Lipophilic:
Literally “fat loving” or “fat seeking”, the property of a chemical
such that it preferentially partitions to lipid, fat or oil phase rather than
aqueous phase. Log
Kow (Octanol/Water Partition Coefficient): The log base 10 of the ratio of
the amounts of chemical in each of the two competing media at steady state. Luteal Function: Refers to the functioning of the corpus luteum, a gland like structure that develops after ovulation in preparation for a pregnancy and secretes estrogen and progesterone. Luteal
Phase: One of the two phases of the menstrual cycle. It occurs after
ovulation and before menstruation. Matrix (Matrices): The medium or material in which a chemical or substances is contained or dissolved (i.e. industrial hemp oil in which THC is dissolved). MBH:
Mediobasal hypothalamus: the site of LHRH release. Mean:
The arithmetic average of a set of data values. Micronuclei:
Tiny nuclei containing chromosome fragments that form as result of errors
during chromosome division caused by chemical exposure to the cell. Mutagenicity: Change to the primary base-pair structure of DNA. NE:
Norepinephrine (noradrenaline) Neoplasm (Tumour): Continued growth of tissues after original growth stimulus has ceased. Cells of a benign tumour are non-invasive and do not form secondary tumours. Cells of a malignant tumour can spread throughout the body, form secondary tumours and invade and destroy other tissues Neoplastic and Non-Neoplastic Lesions: tumourous lesions and non-tumourous lesions. Neurotransmitters:
Signals between nerve cells (neurons) and between nerves cells and their
effector cells are usually conducted by chemical rather than electrical
impulses. Neurotransmitters are chemical whose role is involved in the
chemical synaptic transmission (activation or inhibition) by binding to a
specialized receptor molecule. The nervous system and neuroendocrine system
are controlled and integrated in this manner. Examples of neurotransmitters
that have been found to be affected by cannabinoids include: dopamine,
serotonin, acetylcholine, gamma-aminobutyric acid (GABA), norepinephrine. Non-Detectable: A concentration of a chemical (or substance) in a medium (matrix) that is less than the detectable limit of the analytical method used to measure that chemical (or substance). In exposure assessments it is generally recommended that these values be included in the analysis as values equal to or one-half the detection limit. Non-lymphoblastic
Leukemia: malignant tumour of the blood. No-Observed-Effect-Level
(NOEL): The greatest dose of a chemical administered in a dose-response
toxicity test, at which no response (for a specific effect) is observed in the
test organism. Norepinephrine:
A neurotransmitter of the autonomic nervous system. Most postganglionic
sympathetic fibers release norepinephrine; increases peripheral resistance and
both diastolic and systolic blood pressure. NTP: National
Toxicology (Testing) Program Nutraceuticals:
Nutritional supplements sold commercially that are purported to enhance human
health. Opioidergic
Neurons:
Neurons (nerve cells) that are stimulated by opioid binding to the
receptors in the central and peripheral nervous systems. Some of the brain
opioid binding sites function with pain transmission and the alteration of the
pain threshold. Several nuclei of the thalamus and hypothalamus have been
found to have high density opioid binding sites. Oral
Absorption: Relative amount of chemical (%) when administered orally that
is taken up (absorbed) by the body. See Section 3.2.3.1 of the draft report. Ovarian Hypoplasia: Lower than normal cell division rates in
the ovary. Ovaries:
Female gonads (sex organs) of which there are two in a female mammal. The
ovaries hold the unfertilized oocytes (eggs or ovum) and produce female sex
hormones. P450
inhibitors: Chemicals or substances that impede the metabolic function of
the family of enzymes known as the P450 enzymes. The P450 enzymes play a major
role in the transformation, breakdown and subsequent excretion of a wide range
of chemicals, including known toxic substances. Percentile: The specific value of distribution that divides the data set in such a way that the P percent data are less than or equal to this value and 1-P percent of the data exceed this value. For example, the
95th percentile (P = 0.95) is that value X such that 95% of the
data have values equal or less than X, and 5% of the data have values
exceeding X. By definition the median is the 50th percentile. Perinatal:
The period before and immediately after birth and during weaning. Peripubertal:
The period before and during puberty. Pharmacokinetics:
The study of the time course of absorption, distribution, metabolism, and
excretion of a substance in the body. Pituitary: The small 2 lobed vascular endocrine gland located at the base of the brain in most vertebrates. The anterior lobe secretes hormones that are responsible for the control of other endocrine glands. The posterior lobe secretes hormones that affect renal functions, contractions of smooth muscle and the reproduction. The pituitary gland directly and indirectly controls and regulates most basic bodily functions of mammals. Potentiative: The interactive effect one chemical on another such that an otherwise non-toxic or less-toxic chemical enhances the toxicity of another chemical. Parts
Per Million (PPM):The concentration of a chemical in a medium that is 1
part chemical to 106 parts medium. Typical units are 1 ppm = 1 ug/g
or 1 mg/kg or 1 mg/L. Prenatal
Exposure:
Exposure to a substance while in the uterus (in
utero) before birth. Prepubertal:
The period before onset of puberty. Proenkephalin:
An opiod peptide produced in many areas of the brain. Prolactin
(PRL): A polypeptide hormone produced by the anterior pituitary and
stimulates milk production by the mammary glands. Prostaglandins:
A group of modified fatty acids that act as chemical messengers in most cells
of the body. Psychoactivity/Psychoactive
Effects: Neurological effects that result in the subject perceiving a
feeling of being "stoned". Psychotropic:
Psychoactive Receptor
(Binding Site): Unique site on a molecule that has a specific affinity for
a chemical agonist such that once the agonist is attached to the receptor
subsequent biochemical processes are initiated. Rhabdomyasarcoma: a
malignant tumour of muscular origin. Risk
Assessment: The process through which all the available scientific
information identified in the Hazard Assessment and the results of the
Exposure Assessment are brought together to produce a description based on
scientific principles of the nature and the magnitude or likelihood of adverse
health effects to occur in the consumers through product use or lifestyle
habits. Risk
: The likelihood or probability
that adverse health effects will occur in individuals or populations of
individuals under actual conditions of exposure. SCE:
Sister chromatid exchange, a test for genotoxicity of a chemical or
substance. s.c.
Infusion: A chemical infusion that is delivered via the
subcutaneous route. Serotonergic
Neurons: Nerve cells that release the neurotransmitter serotonin. Spermatogenesis:
Biological process through which male gametes (sperm) are produced. Standard
Deviation (s.d.): A measure of the dispersion (or deviation) of a set of
data from the mean. Steady state: The condition of a system or process that has reached equilibrium over time and then does not change, or that any changes would be negligible over a specified time. Stratum Corneum: The outermost layer of the skin, composed mostly of dead and partially keratinized epidermal cells; provides the major resistance to the absorption into circulation of chemical(s) or substances(s) deposited on the skin. "stone
scale": Method by which variations in degree of psychoactivity
experienced following administration of THC were graded. Subchronic
Toxicity: The damaging effects that occur following repeated daily exposure
to a chemical for a short period of time (e.g. in humans greater than 2 weeks to
7 years ;as defined by the U.S. EPA for animal studies, the oral dosing of a
chemical to test animals for part (not exceeding 10%) of the lifespan, usually 1
to 3 months) Synergistic
Effect: The interaction of more than one chemical acting together to produce
an effect that is greater than the simple sum of their individual effects. TDI:
Tolerable Daily Intake (ug chemical/ kg body weight/d), the daily
amount of chemical that could be consumed by humans on a per body weight basis
without adverse effects on health. Teratogenesis: The process by which defects are formed during reproduction and
development of the embryo or fetus. This can result in embryonic or fetal
mortality, or in the birth of offspring with physical, mental, behavioral or
developmental defects. THC:
Delta-9-tetrahydrocannabinol, the cannabinoid found in Cannabis
sativa that is considered to be
the principle component responsible for its narcotic effects. Threshold
Dose: The dose of a chemical below which no adverse effect occurs. Thyrotropin
Releasing Hormone (TRH): TRH is released by the hypothalamus and stimulates
the pituitary gland to produce thyroptropin, which in turn stimulates the
thyroid gland to produce thyroxine (T4) through a feedback mechanism. Toxicity:
The production of any type of damage or disruption, permanent or impermanent, to
the structure and/or function of any biochemical, cellular, tissue or biological
system in living organisms. Toxicology:
is the scientific study of the adverse effects of chemicals and other substances
on living organisms. Uterine hypoplasia: Lower than normal rate of cell division in the uterus.
This page was last updated on June 20, 2001 |